Exciting news for Rua Bioscience which today announced it has been granted a commercial licence to grow and supply cannabis-derived medicines. The company also announced plans for an IPO on the NZX in the fourth quarter of this year, subject to ongoing market conditions, company developments and other factors.
Northington Partners is proud to be managing the first IPO in New Zealand for 2020 with Rua Bioscience.
To find out more visit:
